drugset / Trial / NCT05765513

HA35 Treatment the Gingival Discomfort as Well as Gingival Redness and Bleeding of Patients With Periodontitis

NCT05765513

Completed 20 enrolled Dove Medical Press Ltd
NaSingle-groupOpen-labelTreatment

Summary

The main objective of this study is to research the treatment of 35 kDa hyaluronan fragment HA35 for Mild periodontitis and associated with gingival discomfort or itchiness.

Timeline

Start
2023-02-02
Primary completion
2023-07-20
Completion
2023-08-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Hyaluronate Other / unclassified 100 mg Other

Indications